Trials / Completed
CompletedNCT01349842
Circulating Tumor Cells to Guide Chemotherapy for Metastatic Breast Cancer
CirCe01 Study: Evaluation of the Use of Circulating Tumour Cells to Guide Chemotherapy From the 3rd Line of Chemotherapy for Metastatic Breast Cancer
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 265 (actual)
- Sponsor
- Institut Curie · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Evaluation of the use of Circulating tumour Cells to guide chemotherapy from the 3rd line of chemotherapy for metastatic breast cancer.
Detailed description
Phase III multicentre, randomized, open-label study comparing early evaluation of the efficacy of chemotherapy by determination of circulating tumour cells versus conventional clinical and radiological evaluation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Blood sampling | 20ml of patient peripherical blood will be collected |
| OTHER | Usual clinical and radiological criteria | Clinical examination, tumoral evaluation |
Timeline
- Start date
- 2010-03-02
- Primary completion
- 2016-01-01
- Completion
- 2018-11-06
- First posted
- 2011-05-09
- Last updated
- 2025-11-24
Locations
7 sites across 1 country: France
Source: ClinicalTrials.gov record NCT01349842. Inclusion in this directory is not an endorsement.